Resveratrol drug trial suspended on safety concerns
A phase 2 human trial investigating the effectiveness of resveratrol for treating multiple myeloma patients has been suspended after 20 percent of the trial’s subjects developed kidney damage.
A phase 2 human trial investigating the effectiveness of resveratrol for treating multiple myeloma patients has been suspended after 20 percent of the trial’s subjects developed kidney damage.
Ingredients suppliers and supplements manufacturers must be more proactive in promoting and communicating key issues facing the dietary supplements industry, stakeholders are saying after a recent fundraiser for a pro-supplements Congressman confirmed...
The European Food Safety Authority has launched a public consultation into its new draft communications strategy, which would make dialogue a new key outcome and lay audiences a new target.
Martek is set to give greater focus to DHA (Docosahexaenoic Acid) products targeted at older adults after a study published this week confirmed the brain health benefits of DHA consumption for that segment of the population.
Marking its first entry into the Asian market, Norwegian krill oil supplier Aker BioMarine has forged a partnership with Compson Trade Co. to distribute its product Superba Krill Oil within Taiwan.
The new director general of the European Commission’s directorate for health and consumer affairs, DG Sanco, has warned manufacturers to expect a tougher line from her than from her predecessor if they fail to make faster progress on improving the...
A European Court of Justice ruling that backs safety as the guiding principle in the establishment of upper safe limits (USLs) for nutrients used in food supplements in individual member states, has been welcomed by European industry groups.
The European Food Standards Authority (EFSA) has not uncovered any safety concerns with the nutritional additive Ferrous Ammonium Phosphate (FAP).